Editor of Patient Care Online.
Machine Learning Model Effectively Predicts Depression Risk in Adults with COPD
The model demonstrated 70.63% accuracy for predicting depression, a common comorbidity seen in COPD and one that increases risk for negative outcomes.
RSV Vaccine Uptake Low Among Eligible Populations: Daily Dose
Your daily dose of the clinical news you may have missed.
Fremanezumab Demonstrates Dual Benefits in Adults with Migraine and Depression
New data from UNITE study suggest fremanezumab was effective in alleviating migraine and comorbid MDD in patients with both conditions.
Stool-Based Testing for Colorectal Cancer Screening is On the Rise: Expert Perspective with Mark Fendrick, MD
The increase in stool-based CRC testing is a logical trend, Hendrick said in an interview, given the convenience plus the 2 million younger adults now eligible for screening.
Stark Regional Disparities in US Life Expectancy Trends Revealed in Comprehensive Birth Cohort Analysis
Life expectancy increased steadily in the US West and Northeast across the 20th century, but gains were just minimal in Southern states, according to the findings.
Pertussis: A Brief Backgrounder for Primary Care
US whooping cough cases have more than doubled over the same time period in 2024 and 2 infants have died from the infection. Here, highlights of the infection, vaccines.
One in 5 US Adults Chooses Against Handwashing, Some Citing it as "Unnecessary," National Survey Finds
While 20% of US adults choose not to wash their hands at appropriate times, nearly half admitted to forgetting to do it, according to a new national survey.
Tirzepatide Switch Outperforms Dulaglutide Dose Escalation in T2D: Daily Dose
Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows
A simple RNA-based blood test can identify the risk of hypertensive disorders in pregnancy months before symptoms appear, researchers reported.
Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose
New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases
New clinical trial findings to be presented at ATS 2025 highlights the effectiveness of dupilumab in treating COPD and asthma.
Millions of US Adults Have Multiple Forms of Eczema, Study Finds
Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.
Low-Dose Colchicine Shrinks Plaque Volume in CAD: Daily Dose
Perceived Stress Tied to Worsened Respiratory Outcomes, Decreased QoL in Adults with COPD
Researchers reported higher levels of perceived stress were associated with worse respiratory outcomes, particularly among individuals with severe COPD.
Novel Study Will Monitor Brain Activity, Daily Function in People with Borderline Personality Disorder
Researchers will study brain activity and daily function in patients with BPD using wearable EEG and digital cognitive tools in a first-of-its-kind real-world study.
Simple Risk Score May Guide CRC Screening Before Age 45: Daily Dose
Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections
Telehealth visits in pediatric primary care were linked to lower antibiotic prescribing rates for respiratory infections compared with in-person visits.
FDA-Cleared AI Lung Sound Tool Extends Specialist Diagnostics to Primary Care, Home
The FDA has cleared TytoCare’s AI-powered Tyto Insights for detecting rhonchi, the third lung sound alongside wheeze and crackles.
Dupilumab Effective, Safe for Severe Pediatric Atopic Dermatitis: Daily Dose
Clinical Pearls from 2025 ACP Internal Medicine Meeting
Expert insights on PAD prevention, boosting colon cancer screening, and expanding obesity treatment options.
Moderate Preterm Birth Linked to Cognitive Deficits in Childhood in New Study
Children born before 34 weeks of gestation exhibited significant cognitive deficits by age 9-10, independent of genetic and socioeconomic factors, reported researchers.
Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose
Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
Upadacitinib shows promising real-world effectiveness for managing moderate-to-severe Crohn disease, even in patients with prior treatment exposure.
Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose
New-Onset Type 2 Diabetes Tied to Higher Risk of Specific Obesity-Related Cancers
New data to be presented at ECO 2025 shows new-onset T2D is linked to increased risk of liver, pancreatic, and bowel cancers, but not endometrial or post-menopausal breast cancer.
Investigational Probiotic Drug Gains FDA Support for Phase 2 Obesity Trial
Northstrive Biosciences received positive FDA feedback for its IND application for EL-22, a probiotic-based treatment for obesity.
Fentanyl Exposures in Children Up 10-Fold in 8 Years: Daily Dose
Immunization in America: Highs and Lows by State
A quick look at the states ranking highest and lowest on metrics including influenza vaccination, tetanus vaccination, HPV vaccination, and more.
Elderly Atopic Dermatitis Cases Up 85% in the US Since 1990, New Study Shows
New data also demonstrated mixed sex disparities in elderly atopic dermatitis prevalence.
Omnipod 5 Boosts Glycemic Control in MDI Users with T1D: Daily Dose
